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Abstract
Vascular Endothelial Growth Factor (VEGF) is the main player in angiogenesis. Because of its crucial role in this process, the
study of the genetic factors controlling VEGF variability may be of particular interest for many angiogenesis-associated
diseases. Although some polymorphisms in the VEGF gene have been associated with a susceptibility to several disorders,
no genome-wide search on VEGF serum levels has been reported so far. We carried out a genome-wide linkage analysis in
three isolated populations and we detected a strong linkage between VEGF serum levels and the 6p21.1 VEGF region in all
samples. A new locus on chromosome 3p26.3 significantly linked to VEGF serum levels was also detected in a combined
population sample. A sequencing of the gene followed by an association study identified three common single nucleotide
polymorphisms (SNPs) influencing VEGF serum levels in one population (Campora), two already reported in the literature
(rs3025039, rs25648) and one new signal (rs3025020). A fourth SNP (rs41282644) was found to affect VEGF serum levels in
another population (Cardile). All the identified SNPs contribute to the related population linkages (35% of the linkage
explained in Campora and 15% in Cardile). Interestingly, none of the SNPs influencing VEGF serum levels in one population
was found to be associated in the two other populations. These results allow us to exclude the hypothesis that the common
variants located in the exons, intron-exon junctions, promoter and regulative regions of the VEGF gene may have a causal
effect on the VEGF variation. The data support the alternative hypothesis of a multiple rare variant model, possibly
consisting in distinct variants in different populations, influencing VEGF serum levels.
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Introduction
Angiogenesis, or the growth of new blood vessels, is required for
any process that results in the accumulation of new tissue as well as
many processes involving tissue remodelling. When the regulation
of angiogenesis fails, blood vessels are formed excessively or
insufficiently. It is thus a characteristic of multiple pathologies
includingcancer,cardiovasculardisease,arthritis,psoriasis,macular
degeneration, and diabetic retinopathy. In particular, insufficient
angiogenesis can be a cause of ischemia, and excessive angiogenesis
can result in tumor neovascularization and growth. The angiogen-
esis process is highly controlled through the balance of pro- and
anti-angiogenic factors. VEGF is a crucial player in angiogenesis as
it represents the principal pro-angiogenic factor. Throughout
development, VEGF orchestrates the process of angiogenesis by
regulating the growth, development, and maintenance of a healthy
circulatory system[1]. During pregnancy, VEGF is involved in
building the placenta. By exerting a powerful antiapoptotic action,
VEGF promotes the growth of new blood vessels in tumorigene-
sis[2]. Because of the crucial role of VEGF, a study of the factors
controlling its variability may be of particular interest for many
angiogenesis-associated disease studies. The very high heritability of
VEGF serum levels reported in the present study and elsewhere [3]
suggests that genetic variability contributes to the variation of the
trait in the population. Specific polymorphisms in the VEGF gene
have been associated with a variation of protein levels [4,5,6] and
with a susceptibility to several diseases, especially cancer develop-
ment and progression [7]. However, no genome-wide search on this
quantitative trait has been reported so far.
In this work we searched for new quantitative trait loci (QTLs)
and polymorphisms influencing VEGF serum levels, in three
isolated populations, each living in a different village in the remote
hilly region of the Cilento and Vallo di Diano National Park,
South Italy. As we recently reported [8,9], each population is
characterized by a large and unique genealogy, including the
majority of the current population, the presence of inbreeding and
a small number of founders.
We identified the 6p21.1 VEGF gene region as the main QTL
for VEGF serum level variation, with a strong and consistent effect
in all three populations. An additional and new QTL was detected
on chromosome 3p26.3. With a weaker effect, this QTL was
detected only in the combined sample of the three populations.
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of the VEGF gene was conducted in sub-samples from each of
the three villages. Three SNPs were found to be significantly
associated with VEGF serum levels in the village of Campora and
a fourth SNP (rs41282644) was significantly associated with VEGF
serum levels in the village of Cardile.
Altogether, the combination of information on linkage and
association in these three population isolates with a common
origin allows us to reject the hypothesis of a direct effect on VEGF
serum levels of the four SNPs identified. The data suggest an effect
of rarer variants, possibly different among the three populations.
These results raise a crucial issue in the search for predictive
and prognostic VEGF polymorphisms for tumors in the general
population.
Results
The characteristics of the study samples are reported in Table 1.
The individuals of the three populations have a comparable mean
age but the proportion of women is higher in Cardile. We recently
reported a significant increase in VEGF serum levels with ageing
in a selected sample [10]. This finding was confirmed in the
complete population samples of the three villages. No difference
was observed in the VEGF serum levels between men and women
(Figure 1). However, the VEGF serum levels were significantly
higher in Campora compared to Gioi (p-value=3.4E-03) and
Cardile (p-value=1.4E-03), while no difference was detected
between Gioi and Cardile (p-value=0.44).
Genome-wide linkage analysis
Genome-wide linkage analysis was performed in the three
population samples on the sub-pedigree sets generated by the
breaking procedure applied to each population genealogy. A very
strong signal was found on chromosome 6p21.1, with the highest
LOD score at the marker D6S459 in Campora (mean LOD
score=7.52, q-value=2.10E-13), in Gioi (mean LOD score=5.31
q-value=3.92E-04), and in the combined sample (mean LOD
score=13.94, q-value=7.27E-22), and at the nearest marker
D6S282 in Cardile (mean LOD score=6.56, q-value=7.01E-05)
(see Table 2). The 6p21.1 region corresponds to the position of the
VEGF gene that is exactly located at 0.5 Mb from the D6S282
marker and at 2 Mb from the D6S459 marker.
An additional linkage was detected on chromosome 3p26.3
(mean LOD score=2.68, q-value=0.012) at marker D3S4559,
able to reach statistical significance in the combined sample
(Table 2). Additional signals were found in Campora, on
chromosome 2p16.3 at marker D2S2156 (mean LOD score=1.98,
q-value=0.016) and on chromosome20q13.13 at marker D20S178
(mean LOD score=1.94, q-value=0.022) (Table 2).
VEGF gene variability
To explore gene variability in our population, an extensive
sequencing of the VEGF gene was carried out in a total group of
136 individuals. In detail, the exons, intron-exon junctions,
promoter and regulative regions were analyzed in 42 individuals
from Campora, 49 individuals from Gioi and 45 individuals from
Cardile. The individuals included in these three hereafter denoted
‘‘detection samples’’ were chosen to best represent the population’s
genetic diversity. Data from NCBI (Assembly GRCh37) report 77
SNPs (64 SNPs and 13 Ins/Del) in the regions of the VEGF gene
included in our analysis. In our detection samples, 36 out of the 77
(32 SNPs and 4 Ins/Del) were detected in at least one population
and 18 new polymorphisms (17 SNPs and 1 Ins/Del) were
identified. Two SNPs (rs3025020 and rs833070) outside the
sequencing regions but available from previous studies were
included in the analysis. The SNP characteristics for the three
population ‘‘detection samples’’ are presented in Table 3. Note that
given the ‘‘detection sample’’ sizes, all but two of the 18 new SNPs
were detected in only one individual (accuracy checked with a
replication of the sequencing for these rare variants, in addition to
the double strand sequencing applied to all variants), the two
remaining SNPs being detected in two individuals from different
populations (see Table 3). A schematic representation of the
position of the SNPs identified along the VEGF gene is reported in
the supplementary figure (Figure S1).
Association study on VEGF gene
In each ‘‘detection sample’’, the SNPs with a minor allele frequency
(MAF) above 5% were tested for association with the VEGF serum
levels. Table 4 displays the results for all the SNPs with a significant
association signal in at least one ‘‘detection sample’’ and for the SNPs
repeatedly reported as associated with VEGF serum levels or
correlated phenotypes in the literature. Significant associations were
found between the VEGF serum levels and three common SNPs in
Campora:thers25648 variant located in the 59UTR, thers3025020
placed in the intron 6 and the rs3025039 located in the 39UTR.
These associations were confirmed in the large population sample
of Campora (Table 5). The TT genotype of the rs3025039 variant was
associated with lower median VEGF levels (CC=435.9 pg/ml vs
TT=295.2 pg/ml) whereas the TT genotype of the rs25648 and
rs3025020 variants was associated with higher levels of VEGF
(CC=382.5 pg/ml vs TT=489.7 pg/ml and CC=365.2 pg/ml vs
TT=447.3 pg/ml, respectively). No linkage disequilibrium was
observed among these three SNPs (LD computed in the population
sample: rs25648-rs3025020 r
2=0.001; rs25648-rs3025039 r
2=0.001;
rs3025020-rs3025039 r
2=0.114).
Surprisingly, no significant associations were found between
these three SNPs and the VEGF levels in the two population
samples from Gioi and Cardile (Table 5). However, the allele
frequencies are not significantly different in the three populations
for SNP rs25648 and rs3025039, and although rs3025020 is less
frequent in Gioi and in Cardile, (0.26 and 0.23 respectively versus
0.46 in Campora), it remains a common SNP in these two villages.
Table 1. Characteristics of the study samples.
Village Campora Gioi Cardile
N6 of Individuals 656 852 449
Women % 53.6 54.5 58.3
Age (mean ± SE) 49.060.84 49.060.78 48.660.98
VEGF (pg/ml)
median 413.5 374.9 355.8
All 95% CI 387.5–445.0 354.0–400.9 337.6–385.3
Range 20.1–2046.6 34.3–1427.7 25.2–1589.3
median 427.2 385.4 378.9
Men 95% CI 381.5–480.4 335.3–443.8 332.9–438.1
Range 43.5–2046.6 42.2–1427.7 26.1–1313.3
median 403.1 369.8 349.2
Women 95% CI 375.5–443.8 345.5–398.9 318.9–381.9
Range 20.1–1811.7 34.3–1311.0 25.2–1589.3
doi:10.1371/journal.pone.0016982.t001
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significantly associated with the VEGF serum levels in the ‘‘detection
sample’’ of Cardile and the association was confirmed in the
population sample of this village but not in the population sample of
Campora nor in that of Gioi (Table 5). In Cardile, the AA genotype
was associated with a lower level of VEGF (AA=118.2 pg/ml vs
GG=391.2 pg/ml). In contrast to the rs25648, rs3025039 and
rs3025020 SNPs, the rs41282644 SNP has a very low frequency in
the Caucasian reference population (MAF=1% in the pilot 1 CEU
sample from the 1000 Genome Project) but has become more
frequent in the Cilento villages (Cardile population sample
MAF=11%, Gioi population sample MAF=8%, Campora population
sample MAF=6%). Note that SNP rs41282644 is not strongly
correlated with the rs25648, rs3025020 and rs3025039 SNPs
(r
2=0.011, 0.057 and 0 with these three SNPs respectively in the
population sample of Cardile).
One significant association was found in Gioi between the
rs2146323 variant, located in the intron 2, and the VEGF serum
levels. However, this association was observed only in the detection sample
(Table 4) and was not confirmed in the population sample of Gioi.
Interestingly, the linkage disequilibrium (LD) among the four SNPs
associated in at least one population was not significantly different
across the populations, as suggested by the results of the global LD
comparison test proposed by Zaykin et al [11] and applied to each
pair of populations: Campora/Cardile, p-value=0.23; Campora/
Gioi p-value=0.63; Gioi/Cardile p-value=0.33 (Figure S1).
Table 2. Genome-wide linkage results for VEGF serum levels in the three populations and combined sample.
Sample Chromosome Marker Location (cM) Mean LOD score (min - max)* q-value
Campora 2p16.3 D2S2156 78.42 1.98 (0.70–2.64) 0.016
6p21.1 D6S459 72.6 7.52 (3.78–10.19) 2.10E-13
20q13.13 D20S178 75.47 1.94 (0.86–3.47) 0.022
Gioi 6p21.1 D6S459 72.6 5.31 (1.40–7.85) 3.92E-04
Cardile 6p21.1 D6S282 68.36 6.56 (3.22–9.10) 7.01E-05
Combined sample 3p26.3 D3S4559 1.08 2.68 (0.83–4.04) 0.012
6p21.1 D6S459 72.6 13.94 (9.15–18.99) 7.27E-22
For each sample the mean LOD scores over all sub-pedigree sets and the corresponding q-value are reported.
*value of the maximum and minimum LOD scores observed over all sub-pedigree sets.
doi:10.1371/journal.pone.0016982.t002
Figure 1. Correlation between VEGF serum levels and age in the populations of Campora, Gioi and Cardile. The increase of VEGF levels
with ageing is reported in each population sample with the related p-values. In Campora, the VEGF levels are higher than in Gioi and Cardile. The
median values and 95% IC of the VEGF levels for each age class are reported.
doi:10.1371/journal.pone.0016982.g001
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Polymorphism Chromosome position Gene location Type Minor Allele Frequency
Campora (N=42) Gioi (N=49) Cardile (N=45)
new1 43735909 Promoter A/G A=0.00 A=0.01 A=0.00
rs12208152 43735980 Promoter C/T T=0.01 T=0.01 T=0.00
new2 43736121 Promoter A/C C=0.00 C=0.00 C=0.03
rs699947 43736389 Promoter A/C A=0.41 A=0.43 A=0.44
rs35569394 43736418 Promoter Ins/Del 18 bp Ins=0.41 Ins=0.44 Ins=0.44
rs1005230 43736496 Promoter C/T T=0.41 T=0.44 T=0.44
rs35864111 43736537 Promoter –/G –=0.41 –=0.44 –=0.44
new3 43736625 Promoter A/G A=0.00 A=0.01 A=0.00
rs36208049 43736679 Promoter G/T T=0.06 T=0.05 T=0.09
rs36208048 43736829 Promoter A/C A=0.01 A=0.01 A=0.00
rs36208050 43736894 Promoter _/G G=0.01 G=0.01 G=0.00
new4 43736938 Promoter C/T T=0.00 T=0.00 T=0.01
new5 43737384 Promoter C/T T=0.00 T=0.00 T=0.01
rs833061 43737486 Promoter C/T T=0.42 T=0.50 T=0.50
rs833062 43737529 Promoter C/T C=0.02 C=0.01 C=0.00
rs57743727 43737698 Promoter AG/_ –=0.00 –=0.00 –=0.03
rs59260042 43737774 Promoter A/C A=0.00 A=0.01 A=0.00
new6 43737781 Promoter C/T T=0.00 T=0.00 T=0.02
new7 43737786 Promoter C/T T=0.00 T=0.01 T=0.00
rs13207351 43737794 Promoter A/G G=0.42 G=0.50 G=0.50
rs28357093 43737805 Promoter A/C C=0.00 C=0.00 C=0.02
rs1570360 43737830 Promoter A/G G=0.46 A=0.39 A=0.32
rs36208384 43737909 Promoter A/C A=0.00 A=0.00 A=0.02
new8 43737983 5’UTR C/G C=0.00 C=0.02 C=0.02
rs2010963 43738350 5’UTR C/G C=0.43 C=0.35 C=0.40
rs25648 43738977 5’UTR C/T T=0.08 T=0.08 T=0.20
rs56302402 43741957 intron 1 A/T T=0.00 T=0.03 T=0.03
new9 43742166 intron 2 A/C A=0.00 A=0.00 A=0.01
rs865577 43742419 intron 2 G/T/C T=0 C=0.19 T=0 C=0.30 T=0 C=0.38
rs833068 43742527 intron 2 A/G A=0.44 A=0.35 A=0.44
rs833070 * 43742626 intron 2 C/T T=0.40 T=0.41 T=0.44
rs2146323 43745095 intron 2 A/C A=0.33 A=0.19 A=0.28
rs3024997 43745107 intron 2 A/G A=0.41 A=0.32 A=0.41
rs3025046 43745452 intron 3 C/G G=0.00 G=0.01 G=0.00
rs3024998 43745577 intron 3 C/T T=0.42 T=0.34 T=0.42
rs3025000 43746169 intron 3 C/T T=0.32 T=0.27 T=0.36
rs3025047 43746410 intron 4 C/T T=0.00 T=0.00 T=0.02
new10 43748302 intron 5 A/G A=0.01 A=0.00 A=0.00
rs3025015 43748350 intron 5 A/G A=0.00 A=0.03 A=0.01
rs3025017 43748357 intron 5 A/G A=0.12 A=0.08 A=0.08
new11 43748449 intron 5 TC/_ –=0.00 –=0.00 –=0.01
rs3025052 43748643 intron 6 C/T T=0.01 T=0.02 T=0.07
rs3025018 43748795 intron 6 C/G/T G=0.08 T=0.08 G=0.05 T=0.09 G=0.02 T=0.11
rs3025020 * 43749110 intron 6 C/T T=0.46 T=0.26 T=0.22
new12 43752397 3’UTR C/T T=0.02 T=0.00 T=0.02
new13 43752518 3’UTR C/T T=0.01 T=0.00 T=0.00
rs3025039 43752536 3’UTR C/T T=0.14 T=0.12 T=0.18
new14 43752596 3’UTR A/G A=0.00 A=0.01 A=0.00
new15 43752607 3’UTR A/G A=0.00 A=0.00 A=0.02
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using successively the three SNPs associated in Campora and all
the four associated SNPs (three associated in Campora and one
associated in Cardile) for haplotype reconstruction. More frequent
haplotypes were tested for association with the VEGF serum levels.
The results show that when the three SNPs associated in Campora
were considered, two haplotypes were found to be associated with
the VEGF serum levels in Campora, but were not associated in
Gioi and in Cardile (Table 6). Interestingly, of the two associated
haplotypes, one (C-C-T haplotype) included all the alleles that in
the single SNP testing were associated with low levels of VEGF,
while the other (T-T-C haplotype) included all the alleles
associated with high levels of VEGF. Further, the association of
the T-T-C haplotype with the VEGF levels was stronger
compared to that of the C-C-T haplotype and it remains
statistically significant also after correction for multiple testing
(Table 6).
When all the four associated SNPs (three associated in Campora
and one associated in Cardile) were used for haplotype
reconstruction, only the T-T-C-G haplotype was still associated
with the VEGF levels in Campora although only at the nominal
level. No association was found between any of the haplotypes
tested and the VEGF levels in Gioi and Cardile.
Linkage on chromosome 6 conditional to VEGF SNP
genotypes
Toevaluatethecontributionofthe associated SNPstothelinkage
signals detected on 6p21.1, the linkage statistics were recomputed
conditional on the associated SNPs. In Campora, the original
linkage peak dropped from a LOD score of 7.52 to a LOD score of
6.82 when the rs3025039 genotypes were taken into account, to a
LOD score of 6.35 in the case of the rs3025020 variant and to a
LODscoreof6.47inthecaseofrs25648.Whenthelinkage statistics
was computed conditional on the three SNP genotypes, the LOD
score dropped to LOD=5.00, highlighting the independence of
these three association signals (Figure 2). A comparable decrease of
the LOD score (35%), was obtained when the linkage analysis was
conditioned on each of the two haplotypes (C-C-T and T-T-C)
associated with the VEGF serum levels in this population.
Similarly, the LOD score of 6.56 detected in Cardile, dropped
to a LOD=5.58 when the linkage statistics was computed
conditional on the rs41282644 SNP genotypes.
The same conditional analyses were carried out in the other
population samples, respectively Gioi and Cardile for SNPs
rs3025039, rs3025020 and rs25648 and Gioi and Campora for
SNP rs41282644. As expected, no variation in the LOD score was
observed in these samples (data not shown).
Table 4. Association results between the SNPs in the VEGF gene and the protein levels in the detection samples.
SNP Campora (N=42) Gioi (N=49) Cardile (N=45)
MAF Effect (CI 95%) p-value MAF Effect (CI 95%) p-value MAF Effect (CI 95%) p-value
rs699947 * 0.41 20.19 (20.71; 0.34) 0.486 0.43 20.22 (20.66; 0.23) 0.339 0.44 20.01(20.45; 0.43) 0.961
rs833061 * 0.42 20.18 (20.56; 0.20) 0.353 0.50 0.26 (20.22; 0.74) 0.287 0.50 20.10 (20.62; 0.43) 0.715
rs1570360 * G=0.46 0.17 (20.18; 0.53) 0.331 A=0.39 0.46 (0.01; 0.92) 0.043 A=0.32 20.12 (20.73; 0.48) 0.696
rs2010963 * 0.43 20.06 (20.55; 0.43) 0.799 0.35 0.04 (20.39; 0.48) 0.840 0.40 20.43 (20.90; 0.04) 0.070
rs25648 * 0.08 1.34 (0.49; 2.20) 2.11E-03 0.08 0.64 (20.04; 1.33) 0.066 0.20 20.05 (20.62; 0.52) 0.862
rs2146323 0.33 20.16 (20.70; 0.38) 0.555 0.19 20.83 (21.35; 20.32) 1.55E-03 0.28 20.34 (20.94; 0.27) 0.275
rs3025020 0.46 0.95 (0.53; 1.37) 1.01E-05 0.26 0.21 (20.30; 0.72) 0.414 0.22 0.47 (20.08; 1.01) 0.093
rs3025039 0.14 21.22 (21.93; 20.51) 7.45E-04 0.12 0.25 (20.35; 0.85) 0.418 0.18 20.04 (20.68; 0.61) 0.906
rs41282644 0.00 --- --- 0.07 0.31 (20.52; 1.13) 0.463 0.10 1.27 (0.51; 2.03) 1.03E-03
The SNPs significantly associated in the detection sample of each population are reported. The results for the SNP (*) repeatedly associated with VEGF levels and/or
related diseases in the literature are also presented.
p-value threshold corrected for multiple testing=0.003.
doi:10.1371/journal.pone.0016982.t004
Polymorphism Chromosome position Gene location Type Minor Allele Frequency
Campora (N=42) Gioi (N=49) Cardile (N=45)
new16 43753005 3’UTR A/G A=0.01 A=0.00 A=0.00
rs3025040 43753051 3’UTR C/T T=0.13 T=0.11 T=0.18
rs10434 43753212 3’UTR A/G A=0.24 A=0.38 G=0.49
new17 43753292 3’UTR C/T T=0.00 T=0.00 T=0.01
rs3025053 43753325 3’UTR A/G A=0.07 A=0.06 A=0.08
rs41282644 43753722 3’UTR A/G A=0.00 A=0.07 A=0.10
new18 43753882 3’UTR A/G G=0.00 G=0.01 G=0.00
The 26 polymorphisms having a MAF.5% in at least one of the samples are reported in bold. New SNPs, not reported in the NCBI, are denoted ‘‘new’’. Two SNPs (*),
already available from previous studies and located outside the sequencing region, were included in the study.
doi:10.1371/journal.pone.0016982.t003
Table 3. Cont.
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A
Haplotype Frequency Association test
Campora Gioi Cardile Campora Gioi Cardile
Z p-value
* Z p-value Z p-value
CTC 0.383 0.208 0.176 1.75 0.080 20.20 0.844 20.16 0.871
CCC 0.381 0.575 0.566 21.08 0.280 21.03 0.304 0.79 0.430
CCT 0.133 0.127 0.161 22.06 0.039 1.16 0.244 20.31 0.758
TCC 0.049 0.062 0.064 0.44 0.662 20.21 0.831 20.80 0.424
TTC 0.027 0.017 0.028 2.79 0.005 0.12 0.901 20.50 0.616
TCT 0.026 0.001 0.005 20.44 0.657 - - - -
TTT 0 . 0 0 1 00 ------
CTT 0 0.010 0.001 - - - - - -
*p-value threshold corrected for multiple testing=0.008.
B
Haplotype Frequency Association test
Campora Gioi Cardile Campora Gioi Cardile
Z p-value* Z p-value Z p-value
CTCG 0.388 0.208 0.182 1.94 0.052 20.20 0.846 20.12 0.902
CCCG 0.341 0.534 0.458 21.61 0.107 20.91 0.365 1.07 0.285
CCTG 0.134 0.126 0.162 21.40 0.161 1.34 0.180 20.003 0.998
CCCA 0.045 0.048 0.102 0.24 0.810 0.01 0.989 20.87 0.385
TCCG 0.039 0.046 0.064 0.17 0.865 0.08 0.939 21.10 0.273
TTCG 0.024 0.016 0.025 2.37 0.018 0.14 0.892 20.30 0.764
TCTG 0.021 0.001 0.004 21.24 0.215 - - - -
TCCA 0.005 0.01 0.002 - - - - - -
TCTA 0 . 0 0 1 00 ------
TTCA 0 . 0 0 1 00 ------
CTCA 0.001 0.001 0 - - - - - -
CTTG 0 0.01 0.001 - - - - - -
CCTA 0 0 0 . 0 0 1 ------
*p-value threshold corrected for multiple testing=0.007.
Associations between the rs25648, rs3025020 and rs3025039 haplotypes and the VEGF serum levels (A) and associations between the rs25648, rs3025020, rs3025039
and rs41282644 haplotypes and the VEGF serum levels (B) in the population samples of Campora, Gioi and Cardile are presented. Only the haplotypes with a
frequency.1% were tested.
doi:10.1371/journal.pone.0016982.t006
Table 5. Association results between the SNPs in the VEGF gene and the protein levels in the population samples.
SNP Campora (N=656) Gioi (N=852) Cardile (N=449)
MAF Effect (CI 95%) p-value MAF Effect (CI 95%) p-value MAF Effect (CI 95%) p-value
rs25648 0.11 0.38 (0.20; 0.55) 2.67E-05 0.09 0.13 (20.10; 0.35) 0.276 0.11 20.20 (20.49; 0.10) 0.185
rs3025020 0.4 0.22 (0.10; 0.33) 3.18E-04 0.26 0.05 (20.10; 0.20) 0.498 0.23 20.04 (20.27; 0.19) 0.702
rs3025039 0.17 20.25 (20.40; 20.10) 1.30E-03 0.15 20.06 (20.25; 0.12) 0.496 0.19 0.16 (20.09; 0.41) 0.2
rs41282644 0.06 0.13 (20.12; 0.39) 0.294 0.08 20.06 (20.30; 0.19) 0.655 0.11 0.59 (0.28; 0.89) 1.75E-04
Only the SNPs significantly associated in the population sample of each village, three SNPs in Campora and one in Cardile, are reported.
p-value threshold corrected for multiple testing=0.01.
doi:10.1371/journal.pone.0016982.t005
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In this study, we reported a high heritability of VEGF serum
levels in our three samples (0.86, 0.80 and 0.89) and a very
consistent and strong linkage of this trait with the VEGF gene
region. Our genome-wide search detected three additional linkage
signals outside the VEGF gene region. A signal on chr3p26 was
observed but only reached significance when the three population
samples were combined to increase the power, which suggests a
weaker effect of this QTL. Further, no clear candidate genes could
be identified in this region. Two additional signals were found on
2p16.3 and 20q13.13. Although not consistent across the
populations and not detected in the combined sample, these
might be of interest since interesting candidate genes are located in
these regions. In fact, the EPAS1 gene, located on 2p16.3, is
known to be involved in the transcriptional regulation of VEGF
[12] and the NCOA-3 (SRC-3) gene, located on 20q13.13, is part
of a multi-subunit co-activation complex including the p300/CBP-
associated factor and the CREB binding protein [13], that
participates in the induction of hypoxia-responsive genes,
including the VEGF gene [14].
Altogether, the genome-wide linkage results suggest that most of
the genetic variability accounting for the VEGF heritability comes
from the VEGF gene region on chr6p21.
Several SNPs in the VEGF gene have been associated with
VEGF protein levels and/or with a susceptibility to (or the severity
of) several cancers such as breast, lung, colorectal, bladder prostate
and gastric [6,15,16,17,18,19]. As an increased VEGF expression
has been associated with tumor progression and metastasis, these
disease associations may well indirectly reflect the effect of genetic
variation on VEGF levels. Among the VEGF SNPs, those
frequently reported to be associated are: rs699947, rs833061,
rs1570360, rs2010963, rs3025039 and rs25648 [7]. As recently
discussed by Jain et al [7], the lack of consensus among association
studies for these SNPs argues against them having a causal role in
cancer development [7].
In our study, associations between rs3025039 and rs25648 and
VEGF levels were detected in Campora but not in the two other
villages, although these two SNPs have a similar frequency and LD
pattern in all three villages. Associations with the other reported
SNPs (rs699947, rs833061, rs1570360, rs2010963) could not be
identified and new association signals were discovered: rs3025020
in Campora and rs41282644 in Cardile.
From the analysis of haplotypes involving the rs25648-
rs3025020- rs3025039 SNPs, we note that in Campora the T-T-
C haplotype is more strongly associated with the VEGF levels than
the C-C-T haplotype and that it is still associated when the
rs41282644 G allele was added (T-T-C-G) to the haplotype.
However, the overall haplotype association results, although
interesting, are less significant then the single SNP association
results, as expected given that all of these are common SNPs and
there is a very low LD between them.
All the associated SNPs in our study contribute to the linkage
signal, but none of them explains the majority of the signal, even
when considered together but independently (3 SNPs in Campora
explain 35% of the linkage signal) or as a haplotype. The detection
of different association signals in populations with a very similar
genetic background and in which a strong linkage was detected,
strongly suggests that these cannot point to functional variants, but
only to proxies correlated to the functional variants.
Whether these variants are more likely to be rare or common,
different or similar among populations remains an open question.
Still, given that the LD patterns among common SNPs in the
region are relatively similar, if common causal variants were
involved, their association with rs3025039, rs25648, rs3025020 or
rs41282644 should not be specific to Campora or Cardile. These
SNPs should be proxies in all three populations. On the contrary,
rare variants, more sensitive to genetic drift, could well display a
discordant LD pattern with common variants among the three
populations, explaining the discordant association results. A
further study of the region, including a sequencing of the whole
Figure 2. Graphical representation of the proportion of linkage explained by the SNP in Campora (A) and Cardile (B). The
percentages reported correspond to the mean LOD score over all sub-pedigree sets analyzed conditional on SNP genotypes divided by the mean
LOD score over all sub-pedigree sets analyzed unconditionally. A decrease of the linkage peak is observed after adjusting for the genotypes at each
associated SNP. A greater effect is observed when the three SNPs detected in Campora are considered simultaneously.
doi:10.1371/journal.pone.0016982.g002
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elucidate this hypothesis.
From a more methodological perspective, this work suggests
that our study design, able to provide complementary information
on linkage and association in three isolated populations with
similar common genetic variations but possibly divergent rarer
variations, is particularly powerful in a discrimination between
causal and non causal variants.
Materials and Methods
Population sample and VEGF measurement
The study includes 1,957 individuals, recruited through a
population-based sampling strategy in three small isolated villages
of the Cilento region, South Italy: 656 individuals from the village
of Campora, 852 from the village of Gioi and 449 from the village
of Cardile. The recruited sample represents about 85% of the
living population of each village. Blood samples were collected in
the morning after the participants had been fasting for at least
12 h. Aliquots of serum were immediately prepared and stored at
280uC, and were subsequently used for the assessment of VEGF
levels. VEGF (pg/ml) was measured using an enzyme-linked
immunosorbent assay, according to the manufacturer’s instruc-
tions (Quantikine
TM, R&D Systems, Minneapolis, MN). The study
design was approved by the ethics committee of Azienda Sanitaria
Locale Napoli 1. The study was conducted according to the
criteria set by the declaration of Helsinki and each subject signed
an informed consent before participating in the study.
Mann-Whitney U test to compare median values in indepen-
dent samples was performed to compare the VEGF serum levels
among population samples. Kruskal-Wallis test was applied to
assess the influence of age on VEGF serum variation. These
analyses were performed with the SPSS software.
Microsatellite Genotyping
A genome-wide scan of 1,122 microsatellites (average marker
spacing of 3.6 cM and mean marker heterozygosity of 0.70) was
performed by the deCODE genotyping service. All subjects having
a VEGF measurement were genotyped. Mendelian inheritance
inconsistencies were checked with the Pedcheck program[20].
Pedigree breaking and linkage analysis
In each village, the vast majority of the phenotyped individuals
were connected through a unique deep pedigree. In Campora, 627
out of the 656 phenotyped individuals were included in a 3,049-
member pedigree. In Gioi, 798 out of the 852 phenotyped
individuals were related through a 4,190-member pedigree. In
Cardile, a pedigree of 2,384 members connected 425 individuals
out of the 449 phenotyped individuals.
The heritability of VEGF serum levels was estimated using the
SOLAR software [21]. A log-transformation was applied to the
trait to eliminate an excess of kurtosis. Gender and age were tested
as covariates, and only age was retained in the final model.
Residuals of the covariate regression were normally distributed
and used for heritability estimations. The estimations of heritabil-
ity were 0.86, 0.80 and 0.89 in Campora, Gioi and Cardile
respectively.
The linkage analysis was performed following a procedure
based on a multiple splitting of the genealogy, that we developed
and already applied to various complex traits [22,23]. This
approach capitalizes on the fact that different family structures
differ in their power to detect linkage [24] by successively
considering the use of different splittings of the population
pedigree. Different splittings of each large population genealogy
into sets of sub-pedigrees were generated following a procedure
that we previously described [25]. Briefly, the sub-pedigree sets
were obtained with the clique-partitioning Jenti method [26],
applying different constraints on the splitting procedure (minimum
and maximum clique size, minimum relationship level among
clique members, and maximum complexity of the resulting
families). A selection of the most informative sets was made by
maximizing the number of related phenotyped pairs of individuals
included in the sets and by minimizing the similarity among the
sets in terms of number of pairs in common. By using this
approach 15 sub-pedigree sets in Campora, 16 in Gioi, 18 in
Cardile and 25 in the combined sample were obtained. The
characteristics of these sub-pedigree sets are reported in a
supplementary table (Table S1).
A linear regression model of the log-transformed VEGF on age
was applied and the residuals were used as a quantitative trait in
the multipoint quantitative linkage analysis on each sub-pedigree
set using the regression-based approach implemented in MER-
LIN-REGRESS [27]. The population mean and variance of
VEGF were computed from all phenotyped individuals in each
population separately, and in the combined sample for the
combined analysis.
The contribution of the associated polymorphisms to the linkage
signal on chromosome 6 was assessed by performing the linkage
analysis on a new phenotype: the VEGF levels adjusted for age
and SNP genotypes with a genotypic modeling of the SNP effect.
To take into account the multiple testing problem created by
both the number of markers tested and the number of pedigree
sets analyzed, we considered a parametric false discovery rate
(FDR) approach.
For each marker in each population, the mean LOD score
statistics over all the sub-pedigree sets was transformed into a test
statistic with a theoretical null distribution following a standard
normal [28]. Indeed, to estimate the q-values (which are, for each
marker, the minimum FDR induced by the rejection of the null
hypothesis), a modelization of the marginal distribution of the test
statistic is required and the transformed test statistic is more easily
modelized.
A K-components Gaussian mixture model with equal variances
was chosen to modelize the marginal distribution of the
transformed test statistics, as such a mixture model efficiently
separates the empirical null distribution (likely to be composite and
different from the theoretical one [28,29]) from the alternative
distribution. For a range of K values (from 2 to 15), the model
parameters were inferred in a Bayesian framework by sampling
from their joint posterior distributions using MCMC samplers
implemented in the WinBUGS software [30]. From the different
models, corresponding to different values of K, we selected the one
having the highest log-likelihood. To estimate the q-values,
without neglecting the fact that the empirical null distribution
may be different from the theoretical one [28,29], the null
distribution in the mixture model was itself modelized by the
mixture of the K0 first components (K0#K). K0 was chosen such
that the L1 distance between the estimated null density and the
density of the theoretical null distribution (a standard normal
distribution) was the minimum. Finally, we report here the
markers with a q-value below 5%[29,31].
Identification and genotyping of SNPs in the VEGF gene
To identify polymorphisms in the VEGF gene, the exons, intron-
exon junctions, promoter and regulative regions were sequenced
in the ‘‘detection samples’’ of individuals selected to best represent the
genetic diversity of each village while maintaining reasonable
sample sizes (42 individuals in Campora, 45 in Cardile and 49 in
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among the oldest individuals for which DNA was available with
children, grand-children and great-grandchildren included in the
population sample. The mean number of direct descendants
(children, grandchildren and great-grandchildren) was 5.8 for the
42 individuals included in the Campora detection sample, 8.3 for
the 45 individuals included in the Cardile detection sample and
9.12 for the 49 individuals included in the Gioi detection sample.
Altogether, 9.8 kb, corresponding to 50% of the entire gene,
were analyzed. The oligonucleotide primers for the amplification
and sequencing of these regions were designed using the primer
prediction program Primer3 (Table S2). The PCR fragments were
obtained by 20 ml reaction containing 0.2 of mM dNTPs, 0.8 mM
of each forward and reverse primer, 1.5 mM of MgCl2, and 40 ng
of genomic DNA as template, with 2 units of recombinant Taq
DNA polymerase. The cycling conditions were as follows: 95uC
for 3 min, followed by 95uC for 30 sec, 60uC for 30 sec, and 72uC
for 30 sec for 35 cycles, and by a final extension at 72uC for 7 min.
The PCR products were purified by using MultiScreen PCRm96
Filter Plates (Millipore) and were sequenced on both strands using
the Applied Biosystems BigDye v3.1 sequencing kit according to
the manufacturer’s recommendations on an Applied Biosystems
3730 DNA Analyzer Sequencer. The sequences were then
analyzed using the SeqAnalysis and BioEdit softwares. The SNP
discovery accuracy was assured by sequencing in two replicates the
fragments including the new SNPs.
As mentioned in the Results section, two SNPs were added to this
panel: rs833070 (located in intron 2) and rs3025020 (located in intron
6) and genotyped using the TaqMan SNP genotyping assay and the
SDS software was used for allele discrimination (Applied Biosystems,
Foster City, CA, USA). The same technology was used to genotype in
the population samples the five SNPs associated in the ‘‘detection
samples’’ (rs25648, rs3025039, rs3025020, rs41282644 and rs2146323).
The rate of successful genotypes was above 95% for each SNP.
Association testing
All frequent SNPs (MAF.5%) identified in the VEGF gene were
tested for association with the log-transformed VEGF adjusted for
age phenotype in the detection samples. The genotype frequencies
of the tested SNPs are reported in a supplementary table (Table
S3). Significant associations were then confirmed in the population
sample of each village (656 individuals in Campora, 852 in Gioi
and 449 in Cardile). To test for association while taking into
account the relatedness between individuals, the phenotypes were
regressed on the genotypes and a Wald Test was applied on the
least square estimator of b (regression coefficient for the genotype
covariate in the regression) with a variance of the estimator
modified to account for the relatedness, using the genealogical
information [9].
To correct for multiple testing, we applied the procedure
proposed by Nyholt [32] and modified by Li and Ji [33]. Briefly, a
number of independent tests (Meff) equivalent to the number of
correlated SNPs tested was estimated from the LD pattern among
the SNPs and a Bonferroni correction for Meff tests was applied to
obtain the corrected p-value threshold.
The global comparison of LD among the rs25648, rs3025039,
rs3025020 and rs41282644 SNPs in the population samples was
conducted using the approach proposed by Zaykin et al [11].
Based on the composite LD coefficient proposed by Weir and
Cockerham [34], this test contrasts the LD matrices with an
empirical assessment of type I error. To account for the inter-
individual relationship, all measures of LD were computed on sub-
samples of poorly related individuals: 163 individuals for the
Campora population sample, 104 individuals for the Cardile population
sample and 111 individuals for the Gioi population sample.
The haplotypes were reconstructed taking advantage of family
information and tested for association with the VEGF levels using
the software FBAT. A biallelic test was performed in which each
haplotype was tested against all the others pooled together and an
additive model was applied. Two analyses were carried out
successively. One used the haplotypes made of the three SNPs
associated in Campora and the other used the haplotypes made of
the four associated SNPs (three associated in Campora and one
associated in Cardile). Only haplotypes having a frequency .1%
were tested for association with the VEGF levels.
Supporting Information
Figure S1 A) Schematic representation of the VEGF gene. The
exons are reported in black, introns in white, regulative regions in
dark grey, and promoter region in light grey. The position of the
56 SNPs identified in the gene is also indicated. The four SNPs
associated with the VEGF levels are framed. B) LD patterns
between the four associated SNPs in Campora, Gioi and Cardile.
R-squared values are indicated.
(TIF)
Table S1 Characteristics of the sub-pedigree sets used in the linkage
study for the VEGF serum levels in Campora, Gioi and Cardile
(DOC)
Table S2 List of the primers designed to sequence VEGF gene
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Table S3 Genotype frequencies in the detection samples of the 26
SNPs analyzed for association with the VEGF levels.
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